Biliary Stent Market Report and Forecast 2024-2032

Global Biliary Stent Market Report and Forecast 2024-2032


The global biliary stent market was valued at USD 141.1 million in 2023. It is expected to grow at a CAGR of 5% during the period 2024-2032. This growth is driven by advancements in stent technologies, increasing demand for minimally invasive procedures, and the rising prevalence of biliary diseases, alongside supportive government policies and healthcare investments. The market is expected to attain a value of USD 218.7 million by 2032.

Global Biliary Stent Market- Analysis

The global biliary stent market is experiencing substantial growth due to advancements in medical technologies and increasing applications in the treatment of biliary diseases. Biliary stents are critical for ensuring proper bile drainage from the liver to the intestines, making them essential in treating biliary obstructions and leaks. These devices play a vital role in various medical procedures, enhancing patient outcomes and supporting the management of biliary conditions effectively.

Market Driver

Technological Advancements: Continuous innovation in biliary stent technology has significantly enhanced the effectiveness and safety of these devices. These advancements are driving market growth as healthcare providers seek more reliable and efficient solutions for biliary drainage. Improved stent designs and materials are making biliary stents more effective and appealing for clinical use.

Increasing Demand for Minimally Invasive Procedures: The growing preference for minimally invasive procedures is driving the demand for biliary stents. These procedures offer shorter recovery times, reduced risk of complications, and improved patient outcomes, making them increasingly popular. The trend towards minimally invasive techniques is enhancing the adoption of biliary stents in medical practice.

Rising Prevalence of Biliary Diseases: The increasing incidence of biliary diseases, such as malignant obstructions and biliary leaks, is driving the demand for biliary stents. These devices are crucial in managing these conditions and ensuring patient safety. The growing elderly population, which is more prone to biliary disorders, is also contributing to increased demand for biliary stent therapies.

Supportive Government Policies: Government initiatives and funding are promoting research and development in the field of biliary stents. Supportive policies and financial incentives for innovation in medical technologies are contributing to market growth, making advanced stent therapies more accessible. Government support is also facilitating faster approval and adoption of biliary stent products.

Market Challenges

High Costs: The high cost of biliary stent therapies can limit accessibility, especially in low-income regions. This financial barrier is a significant challenge for the widespread adoption of stent technologies. Efforts to reduce costs and improve affordability are essential to expanding market reach and ensuring that more patients can benefit from these advanced therapies.

Regulatory Hurdles: Stringent regulatory requirements for the approval and certification of biliary stent products can delay market entry and increase development costs. These regulatory challenges can be significant obstacles for manufacturers aiming to introduce new stent technologies. Navigating complex regulatory landscapes and ensuring compliance with varying international standards are critical to bringing innovative stent solutions to market efficiently.

Potential Complications: The potential complications associated with biliary stent placement, such as infection and stent migration, pose challenges to their use. Ensuring patient safety and addressing these concerns through research and improved stent designs are crucial for market growth. Continuous monitoring and post-market surveillance are necessary to mitigate these risks and maintain the trust of healthcare providers and patients.

Limited Awareness and Training: The limited awareness and understanding of biliary stent therapies among some healthcare providers can hinder market growth. Ensuring proper training and increasing knowledge about the benefits and applications of these devices is crucial. Educational initiatives and professional training programs are necessary to promote the effective use of biliary stents.

Future Opportunities

Emerging Markets: Expanding into emerging markets with improving healthcare infrastructure presents substantial growth opportunities. These regions offer untapped potential for increasing access to biliary stent therapies and improving patient outcomes. Strategic investments and partnerships in these areas can drive market growth and enhance the availability of reliable stent technologies.

Development of Novel Stent Designs: The development of novel biliary stent designs and materials can enhance the effectiveness and safety of these treatments. Innovations in stent formulations and applications are expected to drive market growth by providing more targeted and efficient solutions. New designs that reduce the risk of complications can improve patient outcomes and expand the use of biliary stents.

Collaborations and Partnerships: Strategic partnerships between medical device companies, research institutions, and healthcare providers can drive market expansion. Collaborations can facilitate research, development, and distribution efforts, enhancing the availability and quality of biliary stent therapies. Joint ventures and alliances are essential for leveraging expertise and resources to innovate and expand market offerings.

Increasing Applications in Oncology: The growing use of biliary stents in oncology for the management of malignant obstructions presents new opportunities for market growth. Biliary stents are increasingly being used to ensure proper bile drainage in cancer patients, expanding their application scope. Enhanced techniques and better outcomes in oncology can drive further adoption and development of biliary stent products.

Market Trends

Rising Adoption in Minimally Invasive Surgeries: The adoption of biliary stents in minimally invasive surgeries is increasing due to their effectiveness in treating biliary obstructions and leaks. This trend is driving market growth as more surgeons incorporate stent technologies into their procedures. The positive outcomes associated with biliary stents in minimally invasive surgeries are encouraging wider adoption in medical practice.

Focus on Patient Safety and Efficacy: There is a growing trend towards ensuring the safety and efficacy of biliary stent therapies. Advances in stent designs and materials are enhancing the reliability of these treatments, supporting market growth. The focus on patient safety and improved outcomes is expected to continue driving innovation and adoption in the biliary stent market.

Increased Investment in R&D: Investment in research and development for biliary stent technologies is on the rise. Companies are dedicating significant resources to discovering new applications and improving existing stent designs, fostering innovation in the market. Enhanced R&D efforts are expected to yield advanced stent solutions that offer better efficacy and safety profiles.

Emphasis on Customised Stent Solutions: The trend towards customized stent solutions tailored to specific patient needs is gaining momentum. Customized stents that cater to individual anatomical and clinical requirements are expected to drive market growth by improving patient outcomes and reducing the risk of complications.

Global Biliary Stent Market Segmentation

Market Breakup by Material

Metal

Polymer

The global biliary stent market is segmented by material into metal and polymer. Metal stents, known for their strength and durability, are widely used in managing biliary obstructions. Polymer stents, on the other hand, offer flexibility and are often used in temporary stent placements. Both segments drive market growth by providing diverse options to meet varying clinical needs, supported by continuous technological advancements.

Market Breakup by Application

Malignant Obstruction

Biliary Leaks

Benign Biliary Structures

Others

The market is segmented by application into malignant obstruction, biliary leaks, benign biliary structures, and others. Malignant obstructions dominate due to the critical need for effective bile drainage in cancer patients. Biliary leaks and benign biliary structures also benefit significantly from stent placements, enhancing patient outcomes. The growing use of these devices in other applications highlights their expanding scope, contributing to overall market growth.

Market Breakup by End User

Hospitals

Ambulance Surgical Centres

Specialty Clinics

Others

The market is segmented by end-user into hospitals, ambulance surgical centers, specialty clinics, and others. Hospitals are the primary users of biliary stents, given their critical role in providing comprehensive patient care. Ambulance surgical centers and specialty clinics are increasingly adopting these devices to enhance surgical outcomes and patient safety. The growing use of biliary stents in other healthcare settings reflects their versatility and essential role in modern medical practice, supporting market growth.

Market Breakup by Region

North America 

Europe

Asia Pacific

Latin America

Middle East and Africa

The global biliary stent market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe lead the market due to advanced healthcare infrastructure and high adoption of stent technologies. The Asia Pacific region is emerging as a significant growth area, driven by improving healthcare access and increasing demand for minimally invasive procedures. Latin America the Middle East and Africa are also poised for growth, supported by rising healthcare investments and awareness initiatives.

Global Biliary Stent Market Competitive Landscape

The global biliary stent market features several key players actively shaping the competitive landscape. Notable companies include Cook Group Incorporated, Medtronic Plc, Olympus Corporation, Boston Scientific Corporation (BSC), Conmed Corporation, Becton, Dickinson, and Company (BD), Endo-Flex GmbH, B Braun Melsungen, M.I. Tech Co., Ltd., Cardinal Health Inc., and Merit Medical Systems. These companies engage in activities such as mergers and acquisitions, research initiatives, product introductions, and strategic partnerships to expand their market presence and capabilities. These activities drive innovation and growth within the biliary stent market, ensuring continuous improvement and broadening service offerings.

Key Questions Answered in the Report

What is the expected CAGR of the global biliary stent market during the forecast period 2024-2032?

How are technological advancements in stent technologies driving market growth?

What role does the increasing demand for minimally invasive procedures play in the biliary stent market?

How does the rising prevalence of biliary diseases impact the demand for biliary stents?

What are the key factors contributing to the growth of the biliary stent market in North America, Europe, and Asia Pacific?

How do advancements in medical technologies enhance the effectiveness and safety of biliary stents?

What are the main challenges associated with the high costs of biliary stent therapies?

How do stringent regulatory requirements affect the introduction of new biliary stent technologies?

What are the potential complications associated with biliary stent placement, and how are they being addressed?

How can emerging markets provide growth opportunities for the biliary stent market?

What innovations in stent designs and materials are expected to drive future market growth?

How are strategic partnerships and collaborations influencing research and development in the biliary stent market?

Key Benefits for Stakeholders

The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global biliary stent market from 2017-2032.

The research report provides the latest information on the market drivers, challenges, and opportunities in the global biliary stent market.

The study maps the leading, as well as the fastest-growing, regional markets, enabling stakeholders to identify key country-level markets within each region.

Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition within the global biliary stent industry and its attractiveness.

The competitive landscape section allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biliary Stent Market Overview
3.1 Global Biliary Stent Market Historical Value (2017-2023)
3.2 Global Biliary Stent Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Biliary Stent Market Landscape*
5.1 Global Biliary Stent: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Biliary Stent: Product Landscape
5.2.1 Analysis by Material
5.2.2 Analysis by Application
6 Global Biliary Stent Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Biliary Stent Market Segmentation (2017-2032)
7.1 Global Biliary Stent Market (2017-2032) by Material
7.1.1 Market Overview
7.1.2 Metal
7.1.3 Polymer
7.2 Global Biliary Stent Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Malignant Obstruction
7.2.3 Biliary Leaks
7.2.4 Benign Biliary Structures
7.2.5 Others
7.3 Global Biliary Stent Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Ambulance Surgical Centres
7.3.4 Specialty Clinics
7.3.5 Others
7.4 Global Biliary Stent Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Biliary Stent Market (2017-2032)
8.1 North America Biliary Stent Market (2017-2032) by Material
8.1.1 Market Overview
8.1.2 Metal
8.1.3 Polymer
8.2 North America Biliary Stent Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Malignant Obstruction
8.2.3 Biliary Leaks
8.2.4 Benign Biliary Structures
8.2.5 Others
8.3 North America Biliary Stent Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Ambulance Surgical Centres
8.3.4 Specialty Clinics
8.3.5 Others
8.4 North America Biliary Stent Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Biliary Stent Market (2017-2032)
9.1 Europe Biliary Stent Market (2017-2032) by Material
9.1.1 Market Overview
9.1.2 Metal
9.1.3 Polymer
9.2 Europe Biliary Stent Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Malignant Obstruction
9.2.3 Biliary Leaks
9.2.4 Benign Biliary Structures
9.2.5 Others
9.3 Europe Biliary Stent Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Ambulance Surgical Centres
9.3.4 Specialty Clinics
9.3.5 Others
9.4 Europe Biliary Stent Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Biliary Stent Market (2017-2032)
10.1 Asia Pacific Biliary Stent Market (2017-2032) by Material
10.1.1 Market Overview
10.1.2 Metal
10.1.3 Polymer
10.2 Asia Pacific Biliary Stent Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Malignant Obstruction
10.2.3 Biliary Leaks
10.2.4 Benign Biliary Structures
10.2.5 Others
10.3 Asia Pacific Biliary Stent Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Ambulance Surgical Centres
10.3.4 Specialty Clinics
10.3.5 Others
10.4 Asia Pacific Biliary Stent Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Biliary Stent Market (2017-2032)
11.1 Latin America Biliary Stent Market (2017-2032) by Material
11.1.1 Market Overview
11.1.2 Metal
11.1.3 Polymer
11.2 Latin America Biliary Stent Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Malignant Obstruction
11.2.3 Biliary Leaks
11.2.4 Benign Biliary Structures
11.2.5 Others
11.3 Latin America Biliary Stent Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Ambulance Surgical Centres
11.3.4 Specialty Clinics
11.3.5 Others
11.4 Latin America Biliary Stent Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Biliary Stent Market (2017-2032)
12.1 Middle East and Africa Biliary Stent Market (2017-2032) by Material
12.1.1 Market Overview
12.1.2 Metal
12.1.3 Polymer
12.2 Middle East and Africa Biliary Stent Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Malignant Obstruction
12.2.3 Biliary Leaks
12.2.4 Benign Biliary Structures
12.2.5 Others
12.3 Middle East and Africa Biliary Stent Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Ambulance Surgical Centres
12.3.4 Specialty Clinics
12.3.5 Others
12.4 Middle East and Africa Biliary Stent Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Cook Group Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Developments
17.2.5 Certifications
17.3 Medtronic Plc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Developments
17.3.5 Certifications
17.4 Olympus Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Developments
17.4.5 Certifications
17.5 Boston Scientific Corporation (BSC )
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Developments
17.5.5 Certifications
17.6 Conmed Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Developments
17.6.5 Certifications
17.7 Becton, Dickinson, and Company (BD )
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Developments
17.7.5 Certifications
17.8 Endo-Flex Gmbh
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Developments
17.8.5 Certifications
17.9 B Braun Melsungen
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Developments
17.9.5 Certifications
17.10 M.I. Tech Co., Ltd .
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Developments
17.10.5 Certifications
17.11 Cardinal Health Inc .
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Developments
17.11.5 Certifications
17.12 Merit Medical System
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Company News and Developments
17.12.5 Certifications
18 Global Biliary Stent Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings